Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Royalty Pharma plc (RPRX): A Strategic Investment in Life-Changing Therapies
Alnylam Pharmaceuticals, Inc. (ALNY): Pioneering RNAi Therapeutics with Vutrisiran Expansion
Kodiak Sciences Inc (KOD): A Promising Bet in the Biopharmaceutical Space…
Metagenomi, Inc. (MGX): A Game Changer in Gene Editing and Therapeutic…
ADC Therapeutics SA Soars on Positive Preliminary Results from ZYNLONTA® Clinical…
Finance
Savara Inc. (SVRA): Progress in Rare Respiratory Disease Treatment with MOLBREEVI
Quantum-Si Incorporated (QSI): Transforming Proteomics with Next-Gen Protein Sequencing
Singular Genomics (OMIC) Surges Over 65% Following recent Acquisition Proposal from…
Monte Rosa Therapeutics Soars on Novartis Deal: A Molecular Glue Revolution
Betforward: A Gateway to Sports Betting and Online Gaming
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
Tag: Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) Announce Revenue Of $82.5 Million In Q3...
Kate Hudson
-
November 27, 2020
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Announces Positive Findings From Its ILLUMINATE-B Phase...
Kate Hudson
-
November 5, 2020
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Announces Its Focus And Progress Across Its...
Kate Hudson
-
September 15, 2020
0
Recent Post
Savara Inc. (SVRA): Progress in Rare Respiratory Disease Treatment with MOLBREEVI
Gavins Felicity
-
December 30, 2024
0
Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, saw its stock close at $3.15 on December 27,...
Royalty Pharma plc (RPRX): A Strategic Investment in Life-Changing Therapies
December 30, 2024
Alnylam Pharmaceuticals, Inc. (ALNY): Pioneering RNAi Therapeutics with Vutrisiran Expansion
December 29, 2024
Quantum-Si Incorporated (QSI): Transforming Proteomics with Next-Gen Protein Sequencing
December 29, 2024
Kodiak Sciences Inc (KOD): A Promising Bet in the Biopharmaceutical Space...
December 9, 2024
romabet
mahbet
پین باهیس
bettingmagazine.org
بت کارت
یاس بت
yekbet
megapari
onjabet
alvinbet
betboro
betfa
بت فوروارد
1xbet
1win
betwinner
4shart.com
1xbetgiris.cam
وان کیک بت
وین بت
ریتزوبت
1xbet-ir.com.co
وان ایکس بت
بت فوروارد